• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Training workshops
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

05.11.21

Investigating the Identifiability of One-Stage IVIVC Population Models for Extended-Release Dosage Forms

Trial design and analysis

Pharmacometrics

PAGE 29 (2021) Abstr 9691.

Zannoni S, Brekkan A, Smania G

01.11.21

Effect of Ponesimod Exposure on Total Lymphocyte Dynamics in Patients with Multiple Sclerosis

Pharmacometrics

CNS

Clin Pharmacokinet. 2021 Sep:60(9):1239-1250.

Valenzuela B, Pérez-Ruixo JJ, Leirens Q, Ouwerkerk-Mahadevan S, Poggesi I

01.11.21

Modeling Restoration of Gefitinib Efficacy by Co-Administration of MET Inhibitors in an EGFR Inhibitor-Resistant NSCLC Xenograft Model: A Tumor-in-Host DEB-Based Approach

Oncology

MIDD

Pharmacometrics

CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1396-1411.

Tosca EM, Gauderat G, Fouliard S, Burbridge M, Chenel M, Magni P

01.10.21

Population Repeated Time-to-Event Analysis of Exacerbations in Asthma Patients: A Novel Approach for Predicting Asthma Exacerbations Based on Biomarkers, Spirometry, and Diaries/Questionnaires

MIDD

Pharmacometrics

Respiratory

CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1221-1235.

Svensson RJ, Ribbing J, Kotani N, Dolton M, Vadhavkar S, Cheung D, Staton T, Choy DF, Putnam W, Jin J, Budha N, Karlsson MO, Quartino A, Zhu R

06.09.21

The Population PKPD of Unacylated and Acylated Ghrelin Following Single Rising Doses of BI 1356225 in Healthy Subjects is Impacted by the Time Since Last Meal

Endocrinology

Pharmacometrics

Metabolism

PAGE 29 (2021) Abstr 9806.

Svensson RJ, Henrich A, Bianzano S, Sarubbi D, Röshammar D, Beetz N

06.09.21

Caplacizumab Model-Based Dosing Recommendations In Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura

MIDD

Specific populations

Pharmacometrics

Hematology

PAGE 29 (2021) Abstr 9653.

Sou T, Hansson E, Bergstrand M, Callewaert F, Sousa RP, Sargentini L

06.09.21

Conditional Distribution Modeling for Covariates Simulation Using Classification and Regression Trees Methods

Trial design and analysis

Specific populations

Pharmacometrics

PAGE 29 (2021) Abstr 9632.

Smania G, Jonsson EN

06.09.21

Conditional Distribution Modeling as an Alternative Method for Covariates Simulation: Comparison with Joint Multivariate Normal and Bootstrap Techniques

Trial design and analysis

Specific populations

Pharmacometrics

CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):330-9.

Smania G, Jonsson EN

1 …222324… 34

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture


Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Science & Services
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy